Certara, Inc. (NASDAQ:CERT) Receives $19.71 Consensus Target Price from Analysts

Certara, Inc. (NASDAQ:CERTGet Free Report) has been given an average recommendation of “Hold” by the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $19.71.

A number of analysts recently issued reports on CERT shares. Barclays increased their price target on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a report on Thursday, January 25th. UBS Group initiated coverage on shares of Certara in a report on Thursday, December 7th. They set a “neutral” rating and a $17.00 price target on the stock. Finally, KeyCorp initiated coverage on shares of Certara in a report on Tuesday, December 5th. They set a “sector weight” rating on the stock.

Get Our Latest Research Report on CERT

Insider Buying and Selling

In other Certara news, SVP Richard M. Traynor sold 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $18.00, for a total transaction of $108,000.00. Following the sale, the senior vice president now owns 171,368 shares of the company’s stock, valued at $3,084,624. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Certara

Several institutional investors have recently bought and sold shares of CERT. Tower Research Capital LLC TRC boosted its position in shares of Certara by 584.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,356 shares of the company’s stock worth $25,000 after purchasing an additional 1,158 shares in the last quarter. State of Wyoming boosted its position in shares of Certara by 103.1% in the 2nd quarter. State of Wyoming now owns 2,027 shares of the company’s stock worth $37,000 after buying an additional 1,029 shares in the last quarter. Advisors Asset Management Inc. boosted its position in shares of Certara by 121.1% in the 1st quarter. Advisors Asset Management Inc. now owns 3,108 shares of the company’s stock worth $75,000 after buying an additional 1,702 shares in the last quarter. Covestor Ltd boosted its position in shares of Certara by 14,940.0% in the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock worth $55,000 after buying an additional 3,735 shares in the last quarter. Finally, Captrust Financial Advisors boosted its position in shares of Certara by 135.8% in the 1st quarter. Captrust Financial Advisors now owns 4,628 shares of the company’s stock worth $99,000 after buying an additional 2,665 shares in the last quarter. 67.26% of the stock is owned by institutional investors and hedge funds.

Certara Stock Performance

Shares of NASDAQ CERT opened at $17.89 on Friday. The company’s fifty day moving average price is $16.68 and its 200 day moving average price is $15.52. Certara has a 1 year low of $11.81 and a 1 year high of $24.96. The company has a market capitalization of $2.86 billion, a PE ratio of -85.19, a price-to-earnings-growth ratio of 1.65 and a beta of 1.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.51 and a current ratio of 3.51.

About Certara

(Get Free Report

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.

Featured Articles

Analyst Recommendations for Certara (NASDAQ:CERT)

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.